The Master in Molecular and Cellular Life Sciences (MCLS) is research oriented and takes a multidisciplinary approach to study related to health and disease in cells and organisms. By the end of the programme you will gain sufficient fundamental knowledge to start working on applications in the field of medical and biotechnological issues. These applications may include the development of new medicines and vaccines, new strategies for crop improvement, or the development of enzymes to be used in industry.
MCLS is the ideal Master’s programme if you are interested in molecules as the basis of life and disease and if you want to know how chemistry, biology, biomedical sciences, and physics contribute to our understanding of how these molecules work. The interplay of molecules in cells and organisms is the central focus of the programme.
The Dutch Master's Selection Guide (Keuzegids Masters 2017) ranked this programme as the best in the field of Chemistry in the Netherlands.
You will develop extensive knowledge about cellular processes such as cellular signaling, membrane biogenesis and intracellular transport. You will also learn skills and methods to study the molecules involved in these processes by using biochemistry, structural biology, cell biology, biophysics, computational biology, proteomics and genomics. The programme offers you the flexibility to choose any specialisation within the field of molecular and cellular life sciences.
Within this Master’s programme you can choose one of four tracks:
The first course of its kind in the UK, the Stem Cell & Regenerative Therapies: From Bench to Market MSc combines biological and medical science with business, law and bioethics. It is designed to develop expertise in the biological, commercial and regulatory aspects of cellular therapy, along with its application in biomedicine and equips students to pursue a business-based career in cellular therapy or related disciplines.
Cellular therapies have attracted much interest in recent years in virtually all disciplines of medicine with over 2,700 clinical trials enrolled between 2000 and 2010. As of today, http://www.clinicaltrials.gov has over 27,800 registered cellular therapy clinical trials. The complexity of issues relating to cell manufacturing, the underlying regulatory framework, reimbursement and viable business models, each represent challenges that profoundly undermine the timing and the delivery of a viable healthcare model. Our programme will provide tools that aid the understanding of these complex issues within an integrated and commercial context.
This one-year advanced study course explores the biological, regulatory and business aspects of cellular therapy in the fields of biomedicine. You will study a range of modules that include Stem Cells in Cellular Therapies & Regenerative Medicine and Cellular Therapies in Immunology. You will also complete a dissertation related to business strategy development for cellular therapy.
You will study modules totalling 180 credits throughout the year, with 60 credits coming from the 15,000 – 18,000-word dissertation.
Teaching style and study time
We use lectures, seminars and group tutorials to deliver most of the modules on the course. You will also be expected to undertake a significant amount of independent study.
Methods of assessment
This course is assessed through a combination of the following:
The study time and assessment methods detailed above are typical and give you a good indication of what to expect. However, they may change if the course modules change.
The majority of learning for this degree takes place at the King’s College London Denmark Hill and Guy’s campus. Please note that locations are determined by where each module is taught and may vary depending on the optional modules you select.
King’s College London is regulated by the Higher Education Funding Council for England.
Many of our graduates go on to careers in business development and commercialisation of stem cells products and services, while others go on to pursue a career in the research sector.
The International Master in Bio-Imaging at the University of Bordeaux offers a comprehensive and multidisciplinary academic program in cellular and biomedical imaging, from molecules and cells to entire animals and humans. It is part of the “Health Engineering” program, which combines three academic tracks (Biomedical Imaging, Cellular Bio-Imaging and Bio-Material & Medical Devices).
Built on the research expertise of the researchers at the University of Bordeaux, this Master program provides excellent training opportunities in advanced bio-imaging methods and concepts to understand (patho)-physiological processes through the vertical integration of molecular, cellular and systems approaches and analyses.
Students receive intense and coordinated training in bio-imaging, combining a mix of theoretical and practical aspects. They acquire scientific and technological knowledge and experience in the main imaging techniques used in biomedical research and practice.
Semesters 1 and 2 focus on the acquisition of general knowledge in the field (courses and laboratory training). Semester 3 consists of track specialization in cellular bio-imaging, biomedical imaging and bio-materials & medical devices. Semester 4 proposes an internship within an academic laboratory or with an industrial partner.
Cellular Bio-Imaging track
Biomedical Imaging track
Cellular Bio-Imaging track
Biomedical Imaging track
Graduates will be qualified in the following domains of expertise:
Potential career opportunities include: researcher, service engineer, application scientist, bio-medical engineer, sales engineer, healthcare executive.
Please note that all modules are subject to change. Please see our modules disclaimer for more information.
Reading School of Pharmacy has excellent links with industry, from the big pharma to small and medium-sized enterprises. Many of our graduates go on to work in industry and as researchers at NHS organisations.